C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/551 (2006.01) A61P 25/04 (2006.01) A61P 29/00 (2006.01) C07D 213/72 (2006.01) C07D 215/42 (2006.01) C07D 235/30 (2006.01) C07D 263/58 (2006.01) C07D 277/38 (2006.01) C07D 277/82 (2006.01) C07D 285/08 (2006.01) C07D 295/215 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 413/12 (2006.01) C07D 417/14 (2006.01) C07D 473/32 (2006.01) C07D 491/04 (2006.01) C07D 495/04 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2702772
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
L'invention porte sur des composés de formule (I). Les composés selon l'invention se lient à et sont des agonistes, antagonistes ou agonistes inverses du récepteur CB2 et sont utiles pour le traitement d'une inflammation. Les composés qui sont des agonistes sont en outre utiles pour le traitement de la douleur.
Amouzegh Patricia
Cirillo Pier Francesco
Ermann Monika
Hickey Eugene Richard
Riether Doris
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Diazepane compounds which modulate the cb2 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazepane compounds which modulate the cb2 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepane compounds which modulate the cb2 receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1501060